A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer
Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study proposed the comparison the overall survival, hematological toxicity, pain
reduction score,PSA levels, tumor response, quality of life in two arms of HRPC patients from
different parts of India.